White label ELPA - ClinicalTrials.eu

Study on the Effects of Riociguat in Patients with Early Pulmonary Vascular Disease

Not recruiting

2 1
Investigated Drugs:
- Riociguat
Study on Dantrolene Sodium for Treating Darier Disease in Affected Patients

Not recruiting

2 1 1 1
Investigated Drugs:
- Dantrolene Sodium
Study of Lithium Treatment for Patients with Amyotrophic Lateral Sclerosis (ALS) to Evaluate Survival Rate

Not recruiting

3 1 1
Investigated Diseases:
- Amyotrophic lateral sclerosis
Study on DF1001, Nivolumab, and Paclitaxel for Patients with Advanced Solid Tumors

Not recruiting

1 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
Study on Bempedoic Acid with Atorvastatin and Ezetimibe for Patients with Coronary Artery Disease After Heart Attack

Not recruiting

3 1 1 1
Investigated Drugs:
- Bempedoic Acid
Study of Regorafenib and Avelumab for Adults with Advanced or Metastatic Solid Tumors

Not recruiting

1 1 1 1
Investigated Diseases:
- Neoplasm
Investigated Drugs:
- Avelumab
- Regorafenib
Study on Oxaliplatin and Irinotecan for Patients with Metastatic Colorectal Cancer in the Liver

Not recruiting

3 1 1 1
Investigated Diseases:
- Metastases to liver
- Colorectal cancer
Investigated Drugs:
- Oxaliplatin
Study on Mirvetuximab Soravtansine and Carboplatin for Patients with Recurrent Ovarian Cancer Eligible for Platinum-Based Chemotherapy

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
Study on the Effectiveness and Safety of Pegcetacoplan for Patients with C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

Not recruiting

3 1 1
Investigated Drugs:
- Pegcetacoplan
Study on Using Cetuximab with Fluorescence Endoscopy to Find Primary Tumors in Patients with Unknown Head and Neck Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
- Head and neck cancer
Investigated Drugs:
- Cetuximab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies